Key result
Danaparoid plus abciximab enables successful rotational atherectomy in a patient with heparin antibodies.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Heparin is considered necessary during percutaneous coronary interventions; however, heparin is contraindicated in patients with heparin-induced thrombocytopenia and/or heparin antibodies. We describe the successful use of the heparinoid Orgaran (danaparoid sodium) in addition to abciximab (ReoPro) in a patient with heparin antibodies who required rotational atherectomy.
No takes yet. Share an insight, caveat, or question.
Hale et al. (1998) studied this question. Orgaran (danaparoid sodium) combined with abciximab was used successfully during rotational atherectomy in a patient with heparin antibodies.
Synapse has enriched 10 related papers. Consider them for comparative context: